NSETrading Window26 Jun 2026 · 26 Jun 2026, 02:37 pm

Trading Window

Marksans Pharma Limited · MARKSANS

✦ AI Summary

Marksans Pharma Limited has informed the Exchange regarding the closure of the trading window for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Marksans Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

MARKSANS_26062026143659_Closure_of_Trading_Window.pdf

pdf

Download →
View document text
June 26, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS Subject: Intimation of closure of Trading Window in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir/Madam, In terms of the Company's code of conduct to regulate, monitor and report trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the shares of Marksans Pharma Limited (‘the Company’) by the designated persons of the Company and their immediate relatives will remain closed from Wednesday, July 01, 2026 till 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026. The date of declaration of financial results will be intimated separately in due course of time. Designated Persons of the Company and their immediate relatives shall not trade in the shares of the Company during the aforesaid period of closure of trading window. You are requested to note the above in your records. Thanking You. Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com